$BFACF
Battery Future Acquisition Corp.

2024 Q3 Form 10-Q Financial Statement

#000192998024000550 Filed on November 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $155.4K
YoY Change -78.71%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $155.4K
YoY Change -78.71%
Operating Profit -$155.4K
YoY Change -78.67%
Interest Expense $486.9K
YoY Change -77.97%
% of Operating Profit
Other Income/Expense, Net $505.8K
YoY Change -66.78%
Pretax Income $350.4K
YoY Change -55.64%
Income Tax
% Of Pretax Income
Net Earnings $350.4K
YoY Change -55.87%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share $0.03
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.22K
YoY Change -87.78%
Cash & Equivalents $12.22K
Short-Term Investments
Other Short-Term Assets $21.25K
YoY Change -78.75%
Inventory
Prepaid Expenses $21.25K
Receivables
Other Receivables
Total Short-Term Assets $33.47K
YoY Change -84.49%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $41.88M
YoY Change -66.12%
Other Assets
YoY Change
Total Long-Term Assets $41.88M
YoY Change -66.12%
TOTAL ASSETS
Total Short-Term Assets $33.47K
Total Long-Term Assets $41.88M
Total Assets $41.91M
YoY Change -66.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $153.7K
YoY Change -92.68%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $419.1K
YoY Change -89.12%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $345.0K
YoY Change -90.92%
Total Long-Term Liabilities $345.0K
YoY Change -90.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $419.1K
Total Long-Term Liabilities $345.0K
Total Liabilities $764.1K
YoY Change -90.02%
SHAREHOLDERS EQUITY
Retained Earnings -$3.596M
YoY Change -51.68%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$730.4K
YoY Change
Total Liabilities & Shareholders Equity $41.91M
YoY Change -66.15%

Cashflow Statement

Concept 2024 Q3
OPERATING ACTIVITIES
Net Income $350.4K
YoY Change -55.87%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$71.90K
YoY Change -74.32%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 68.91K
YoY Change -91.17%
NET CHANGE
Cash From Operating Activities -71.90K
Cash From Investing Activities 0.000
Cash From Financing Activities 68.91K
Net Change In Cash -2.990K
YoY Change -256839044300685.0%
FREE CASH FLOW
Cash From Operating Activities -$71.90K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
21250 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
33465 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
111819 usd
CY2024Q3 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
41876683 usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
56708101 usd
CY2024Q3 us-gaap Assets
Assets
41910148 usd
CY2023Q4 us-gaap Assets
Assets
56819920 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
153651 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2368029 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
265479 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2358135 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
419130 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4726164 usd
CY2024Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
345000 usd
CY2023Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3479807 usd
CY2024Q3 us-gaap Liabilities
Liabilities
764130 usd
CY2023Q4 us-gaap Liabilities
Liabilities
8205971 usd
CY2024Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
41876424 usd
CY2023Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
56707840 usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2864949 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3596220 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8094754 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-730408 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-8093891 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
41910146 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
56819920 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
155391 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
728366 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2670974 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-155391 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-728366 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-437360 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2670974 usd
CY2024Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
486847 usd
CY2023Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
2221087 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1803004 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
8881728 usd
CY2024Q3 bfac Interest Earned On Related Party Promissory Note
InterestEarnedOnRelatedPartyPromissoryNote
0 usd
CY2023Q3 bfac Interest Earned On Related Party Promissory Note
InterestEarnedOnRelatedPartyPromissoryNote
-15044 usd
bfac Interest Earned On Related Party Promissory Note
InterestEarnedOnRelatedPartyPromissoryNote
-7306 usd
bfac Interest Earned On Related Party Promissory Note
InterestEarnedOnRelatedPartyPromissoryNote
-27181 usd
CY2024Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-18975 usd
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
683593 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1533294 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1587103 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
505822 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1522450 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4935893 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7267444 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
350431 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
794084 usd
us-gaap Net Income Loss
NetIncomeLoss
4498533 usd
us-gaap Net Income Loss
NetIncomeLoss
4596470 usd
us-gaap Profit Loss
ProfitLoss
4498533 usd
us-gaap Profit Loss
ProfitLoss
4596470 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1803004 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
8881728 usd
bfac Interest On Working Capital Loan Related Party
InterestOnWorkingCapitalLoanRelatedParty
-7306 usd
bfac Interest On Working Capital Loan Related Party
InterestOnWorkingCapitalLoanRelatedParty
-27181 usd
us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
1606901 usd
us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
0 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1587103 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
21250 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-297500 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
61526 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1439707 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-397084 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-933767 usd
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
0 usd
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
1000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
16634422 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
242268708 usd
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
16634421 usd
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
243268708 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
297479 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
1758342 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-16336942 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-241510366 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-99604 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-175425 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
111819 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
299149 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
123724 usd
us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
1601513 shares
bfac Change In Value Of Class A Ordinary Shares Subject To Possible Redemption
ChangeInValueOfClassAOrdinarySharesSubjectToPossibleRedemption
1803005 usd
bfac Change In Value Of Class A Ordinary Shares Subject To Possible Redemption
ChangeInValueOfClassAOrdinarySharesSubjectToPossibleRedemption
9881728 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
3066441 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
0 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
669000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 usd
us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
200 usd
us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
0 usd
CY2024Q3 bfac Percentage Of Amount Of Trust Assets Of Target Company Excluding Underwriting Commission Working Capital And Taxes
PercentageOfAmountOfTrustAssetsOfTargetCompanyExcludingUnderwritingCommissionWorkingCapitalAndTaxes
0.80 pure
CY2024Q3 bfac Percentage Of Public Shareholding To Be Redeemed In Case Of Non Occurrence Of Business Combination
PercentageOfPublicShareholdingToBeRedeemedInCaseOfNonOccurrenceOfBusinessCombination
1 pure
CY2024Q3 us-gaap Minimum Net Worth Required For Compliance
MinimumNetWorthRequiredForCompliance
5000001 usd
CY2023Q2 bfac Additional Per Share Amount Deposited Into The Trust Account
AdditionalPerShareAmountDepositedIntoTheTrustAccount
0.03
CY2023Q2 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
250000 usd
CY2023Q2 bfac Additional Per Share Amount Deposited Into The Trust Account
AdditionalPerShareAmountDepositedIntoTheTrustAccount
0.03
CY2023Q2 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
250000 usd
CY2023Q2 us-gaap Stock Redeemed Or Called During Period Shares
StockRedeemedOrCalledDuringPeriodShares
23063075 shares
CY2023Q2 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
243200000 usd
CY2023Q2 bfac Per Share Amount Withdrawn From The Trust Account
PerShareAmountWithdrawnFromTheTrustAccount
10.55
CY2023Q2 bfac Ordinary Shares Outstanding
OrdinarySharesOutstanding
20061925 shares
CY2023Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
5000001 usd
CY2024Q3 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
5000001 usd
CY2023Q4 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
68200000 usd
CY2023Q4 us-gaap Share Price
SharePrice
10.88
CY2023Q4 bfac Amount Held In Trust Account
AmountHeldInTrustAccount
56300000 usd
CY2023Q4 bfac Ordinary Shares Outstanding
OrdinarySharesOutstanding
13795599 shares
CY2024Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
6433333 usd
CY2024Q3 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10.20
CY2024Q1 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
2397441 usd
CY2024Q3 bfac Net Working Capital
NetWorkingCapital
385665 usd
CY2021Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25000 usd
CY2024Q2 bfac Net Working Capital
NetWorkingCapital
1100000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of unaudited condensed financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed financial statements and the reported amounts of expenses during the reporting period. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. </p>
CY2024Q3 us-gaap Cash
Cash
12215 usd
CY2023Q4 us-gaap Cash
Cash
111819 usd
bfac Term Of Restricted Investments
TermOfRestrictedInvestments
P185D
CY2023Q2 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0465 pure
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows.  
CY2024Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2024Q3 bfac Warrant Redemption Price
WarrantRedemptionPrice
0.01
CY2021Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25000 usd
CY2021Q3 us-gaap Share Price
SharePrice
0.003
CY2021Q3 bfac Founder Shares
FounderShares
7187500 shares
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
908000 usd
CY2024Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
6433333 usd
CY2024Q1 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
2397441 usd
CY2024Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
265479 usd
CY2024Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10.88
CY2023Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10.85
CY2024Q1 bfac Strike Price
StrikePrice
11.50
CY2023Q4 bfac Strike Price
StrikePrice
11.50
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y4M28D
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P1Y5M23D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.004 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.007 pure
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.045 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0452 pure
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023Q4 bfac Preferred Stock Shares Authorized In Equity
PreferredStockSharesAuthorizedInEquity
1000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
dei Entity Central Index Key
EntityCentralIndexKey
0001880441
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2024Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
34500000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2023Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
0 usd
CY2024Q1 us-gaap Notes Payable Current
NotesPayableCurrent
0 usd
CY2024Q3 bfac Preferred Stock Shares Authorized In Equity
PreferredStockSharesAuthorizedInEquity
1000000 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41158
dei Entity Registrant Name
EntityRegistrantName
Battery Future Acquisition Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1618517
dei Entity Address Address Line1
EntityAddressAddressLine1
8 The Green
dei Entity Address Address Line2
EntityAddressAddressLine2
#18195
dei Entity Address City Or Town
EntityAddressCityOrTown
Dover
dei Entity Address State Or Province
EntityAddressStateOrProvince
DE
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19901
dei City Area Code
CityAreaCode
929
dei Local Phone Number
LocalPhoneNumber
465-9707
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12215 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
111819 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
0 usd
CY2023Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
3683125 shares
CY2024Q3 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
11.37
CY2023Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
5170599 shares
CY2023Q4 us-gaap Temporary Equity Redemption Price Per Share
TemporaryEquityRedemptionPricePerShare
10.97
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
34500000 shares
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
437360 usd
CY2024Q3 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
0 usd
CY2023Q3 us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
0 usd
us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
1606901 usd
us-gaap Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
0 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-8093891 usd
CY2024Q1 bfac Forgivness Of Due To Related Parties
ForgivnessOfDueToRelatedParties
3066441 usd
CY2024Q1 bfac Cancellation Of Private Warrants
CancellationOfPrivateWarrants
1601513 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3453001 usd
CY2024Q1 bfac Accretion For Shares Subject To Possible Redemption
AccretionForSharesSubjectToPossibleRedemption
-669171 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-642107 usd
CY2024Q2 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0 usd
CY2024Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
695102 usd
CY2024Q2 bfac Accretion For Shares Subject To Possible Redemption
AccretionForSharesSubjectToPossibleRedemption
-646987 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-593992 usd
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
350431 usd
CY2024Q3 bfac Accretion For Shares Subject To Possible Redemption
AccretionForSharesSubjectToPossibleRedemption
-486847 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
-730408 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-2156204 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
2176769 usd
CY2023Q1 bfac Accretion For Shares Subject To Possible Redemption
AccretionForSharesSubjectToPossibleRedemption
-3787699 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-3767134 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1625617 usd
CY2023Q2 bfac Accretion For Shares Subject To Possible Redemption
AccretionForSharesSubjectToPossibleRedemption
-3372942 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-5514459 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
794084 usd
CY2023Q3 bfac Accretion For Shares Subject To Possible Redemption
AccretionForSharesSubjectToPossibleRedemption
-2721087 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-7441462 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1533294 usd
bfac Cash Withdrawn From Trust Account In Connection With Redemption
CashWithdrawnFromTrustAccountInConnectionWithRedemption
-16634422 usd
bfac Cash Withdrawn From Trust Account In Connection With Redemption
CashWithdrawnFromTrustAccountInConnectionWithRedemption
-243268708 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12215 usd
bfac Term Of Restricted Investments
TermOfRestrictedInvestments
P185D
CY2023Q2 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0465 pure
us-gaap Accretion Expense
AccretionExpense
100000 usd
CY2023Q2 bfac Amount Held In Trust Account
AmountHeldInTrustAccount
120900000 usd
CY2024Q3 us-gaap Cash
Cash
12215 usd

Files In Submission

Name View Source Status
bfac-20240930_cal.xml Edgar Link unprocessable
0001929980-24-000550-index-headers.html Edgar Link pending
0001929980-24-000550-index.html Edgar Link pending
0001929980-24-000550.txt Edgar Link pending
0001929980-24-000550-xbrl.zip Edgar Link pending
bfac-20240930.xsd Edgar Link pending
bfac_10q.htm Edgar Link pending
bfac_ex31.htm Edgar Link pending
bfac_ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bfac-20240930_def.xml Edgar Link unprocessable
bfac-20240930_lab.xml Edgar Link unprocessable
bfac-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bfac_10q_htm.xml Edgar Link completed